LF
CADL icon

LifeSteps Financial’s Candel Therapeutics CADL Stock Holding History

LifeSteps Financial’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10 Buy
+1
New +$8 ﹤0.01% 790

Other funds holding CADL

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
CSP
Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

LifeSteps Financial's CADL Position: Q2 2026 in Review

LifeSteps Financial opened a new position in Candel Therapeutics (CADL) in Q2 2026: 1 share worth $10. The stake represents ﹤0.01% of the portfolio and ranks #790 among its holdings.

6 funds tracked by Wall St. Rank hold CADL as of Q2 2026.

  • LifeSteps Financial held 1 share of Candel Therapeutics worth $10 as of Q2 2026.
  • Candel Therapeutics was a new LifeSteps Financial position in Q2 2026.
  • Candel Therapeutics made up ﹤0.01% of LifeSteps Financial's portfolio in Q2 2026, its #790 holding.
  • 6 funds tracked by Wall St. Rank held Candel Therapeutics as of Q2 2026.

Based on LifeSteps Financial's 13F filing for Q2 2026, filed 17 Jul 2026.